# Vesicor Therapeutics, Inc. — Form D

Vesicor Therapeutics, Inc. of SAN GABRIEL, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-14. The offering totals $3.0M, of which $515K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-05-14
- Form: D
- Accession: 0000935836-25-000325
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $515K
- Remaining: $2.5M
- Minimum investment: $20K
- Investors: 12
- Date of first sale: 2024-07-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-546051

## Issuer

- Name: Vesicor Therapeutics, Inc.
- CIK: 0001993074
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 207 S. SANTA ANITA STREET, SUITE P-15, SAN GABRIEL, CA, 91776
- Phone: (626) 400-6603

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Luo Feng | Director | San Gabriel, CA |
| Warren Hosseinion | Director | Atlanta, GA |
| Oded Levy | Director | San Gabriel, CA |
| Michael Bowen | Executive Officer | SUWANEE, GA |
| Luo Feng | Executive Officer | San Gabriel, CA |
| Warren Jr. Hosseinion | Executive Officer | San Gabriel, CA |
| Warren Hosseinionn | Director | Chicago, IL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-09-14](https://search.stillhousedata.com/formd/0001486189-23-000028) | D | $3.0M | $200K |

## More

- [CIK 1993074 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1993074&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000935836-25-000325.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.